# Maximus, Inc.: Form 10-Q for the period ended Mar 31, 2015

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2015-05-08
- Accepted by EDGAR: May 8, 2015, 11:49 ET
- Period: 2015-03-31
- Accession: 0001104659-15-035883
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000110465915035883/a15-6177_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000110465915035883/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-01-01 to 2015-03-31 | $481.8m | us-gaap:Revenues |
| Revenue | 6 months, 2014-10-01 to 2015-03-31 | $948.8m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2015-01-01 to 2015-03-31 | $357.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2014-10-01 to 2015-03-31 | $705.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2015-01-01 to 2015-03-31 | $124.3m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2014-10-01 to 2015-03-31 | $243.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2015-01-01 to 2015-03-31 | $59.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2014-10-01 to 2015-03-31 | $111.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-01-01 to 2015-03-31 | $62.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2014-10-01 to 2015-03-31 | $127.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2015-01-01 to 2015-03-31 | $23.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2014-10-01 to 2015-03-31 | $47.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-01-01 to 2015-03-31 | $38.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2014-10-01 to 2015-03-31 | $80.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-01-01 to 2015-03-31 | $0.58 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2014-10-01 to 2015-03-31 | $1.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-01-01 to 2015-03-31 | $0.59 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2014-10-01 to 2015-03-31 | $1.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-01-01 to 2015-03-31 | 66,987,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2014-10-01 to 2015-03-31 | 66,947,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2014-10-01 to 2015-03-31 | $62.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2014-10-01 to 2015-03-31 | $44.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2014-10-01 to 2015-03-31 | $5.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2014-10-01 to 2015-03-31 | $32.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-03-31 | $114.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-03-31 | $570.0m | us-gaap:AssetsCurrent |
| Total assets | at 2015-03-31 | $955.0m | us-gaap:Assets |
| Current liabilities | at 2015-03-31 | $272.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-03-31 | $366.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2015-03-31 | $587.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 18,392 characters.

*The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2014, filed with the Securities and Exchange Commission on November 17, 2014.*

### Business Overview

We provide business process services (BPS) to government health and human services agencies under our mission of *Helping Government Serve the People.®* We are one of the largest pure-play health and human services BPS providers to governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia. We use our experience, business process management expertise and advanced technological solutions to help government agencies run efficient and cost-effective programs, improve program accountability and outcomes and enhance the quality of services provided to program beneficiaries.

Over the past five years, our business has grown significantly. We believe this growth has been driven by economic and demographic factors, such as aging populations and increased demand for health care, and the need for governments to operate programs effectively and efficiently. This growth has been driven by reform efforts in the United States, including the Affordable Care Act, as well as internationally with various programs in Australia and the United Kingdom.

We believe that governments will continue to seek opportunities to enhance existing processes or address new challenges through companies such as MAXIMUS. We believe that a combination of our innovative technical solutions, deep subject matter expertise, stringent adherence to our Standards of Business Conduct and Ethics, robust financial performance and global experience gives existing and future customers the confidence that MAXIMUS can reliably operate their high-profile public health and human services programs.

On April 1, 2015, we acquired Acentia LLC (“Acentia”) for an estimated cash consideration of $294 million. Acentia provides system modernization, software development, program management and other information technology services and solutions to the United States Federal Government. We acquired Acentia, among other reasons, to expand our ability to provide complementary business services and offerings across government markets. We have provided certain unaudited pro forma financial information for Acentia in a Current Report on Form 8-K dated May 8, 2015. The unaudited pro forma financial information from Acentia for the year ended September 30, 2014 was $212 million and pro forma diluted earnings per share increased from $2.11 to $2.25. The pro forma information is based upon historical information and is not necessarily indicative of what would have been achieved or will be achieved.

On April 7, 2015, we acquired 70% of the ownership interests of Remploy (2015) Limited, whose assets had previously operated under the “Remploy” tradename. The remaining 30% is held in a trust for the benefit of the employees. Remploy provides services to the United Kingdom government, particularly in supporting employment opportunities for the disabled. We acquired Remploy to complement our welfare-to-work services in the United Kingdom. We expect the acquisition of Remploy will increase our revenue for the second half of the year by approximately $30 million to $35 million.

Our financial results for the three and six month periods ended March 31, 2015 do not include any results related to Acentia or Remploy. The results of these businesses will be included in the Health and Human Services Segments, respectively, in future financial reporting. We expect the acquisitions of Acentia and Remploy will increase our revenues for fiscal year 2015 by $140 million to $160 million and diluted earnings per share by $0.07 to $0.09. The acquisition of Acentia was funded, in part, through a borrowing of $225 million on our revolving line of credit.

### Results of Operations

#### Consolidated

The following table sets forth, for the periods indicated, selected statements of operations data:

*(amounts in thousands, except per share data)*

|  | Three Months Ended March 31, 2015 | 2014 | Six Months Ended March 31, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $481,794 | $439,015 | $948,837 | $845,607 |
| Gross profit | $124,345 | $120,672 | $243,612 | $226,588 |
| Gross profit percentage | 25.8% | 27.5% | 25.7% | 26.8% |
| Selling, general and administrative expenses | $59,392 | $53,624 | $111,353 | $104,889 |
| Selling, general and administrative expense as a percentage of revenue | 12.3% | 12.2% | 11.7% | 12.4% |
| Amortization of intangible assets | 1,432 | 1,468 | 2,907 | 2,823 |
| Acquisition-related expenses | 1,514 | — | 2,114 | — |
| Legal and settlement expenses | — | 600 | — | 600 |
| Operating income | $62,007 | $64,980 | $127,238 | $118,276 |
| Operating margin | 12.9% | 14.8% | 13.4% | 14.0% |
| Interest and other income, net | 219 | 476 | 1,120 | 808 |
| Income before income taxes | 62,226 | 65,456 | 128,358 | 119,084 |
| Provision for income taxes | 23,198 | 23,995 | 46,980 | 44,268 |
| Effective tax rate | 37.3% | 36.7% | 36.6% | 37.2% |
| Net income | $39,028 | $41,461 | $81,378 | $74,816 |
| (Income)/loss attributable to noncontrolling interests | (220) | $(254) | $(709) | $250 |
| Net income | $38,808 | $41,207 | $80,669 | $75,066 |
| Basic earnings per share attributable to MAXIMUS | $0.59 | $0.61 | $1.22 | $1.10 |
| Diluted earnings per share attributable to MAXIMUS | $0.58 | $0.59 | $1.20 | $1.08 |

The following provides an overview of the significant elements of our Consolidated Statements of Operations. As our business segments have different factors driving revenue growth and profitability, the sections that follow cover these segments in greater detail.

All revenue growth for the periods presented is organic, driven by new work and growth in existing work principally within our Health Services Segment. Overall, profit margins have declined due to expected lower volumes in our federal Medicare appeals business.

Acquisition-related expenses are costs incurred related to the acquisitions of Acentia and Remploy. These costs include professional fees and other transaction-related costs. Additional expenses were incurred in April 2015 as the transactions closed.

Our effective tax rate for the six months ended March 31, 2015 was 36.6%. We anticipate that our tax rate will increase in the second half of this fiscal year as Acentia operates in the United States and will, accordingly, incur taxes at rates higher than our current effective rate.

#### Health Services Segment

The Health Services Segment provides a variety of business process services, as well as related consulting services, for state, provincial and national government programs, including Medicaid, CHIP, Supplemental Nutrition Assistance Program (SNAP), Medicare, the Affordable Care Act (ACA), the Health Assessment and Advisory Service in the United Kingdom and Health Insurance BC (British Columbia).

*(amounts in thousands)*

|  | Three Months Ended March 31, 2015 | 2014 | Six Months Ended March 31, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $370,383 | $323,598 | $721,682 | $622,182 |
| Gross profit | 91,887 | 84,868 | 177,302 | 161,374 |
| Operating income | 51,113 | 49,735 | 102,271 | 92,066 |
| Gross profit percentage | 24.8% | 26.2% | 24.6% | 25.9% |
| Operating margin percentage | 13.8% | 15.4% | 14.2% | 14.8% |

Revenue for the three and six months ended March 31, 2015 increased 14% and 16% compared to the same period in fiscal year 2014. Revenue for the current year benefitted from new work as well as expansion of existing contracts including expected accretive change orders. These benefits have been offset by anticipated declines in revenue in our federal Medicare appeals business.

Our gross and operating margins have declined in the three and six months ended March 31, 2015 due to lower volumes in our federal Medicare appeals business and new contracts in start-up phase.

During the second half of fiscal year 2015, we anticipate the benefits of Acentia’s business and the United Kingdom Health Advisory and Assessment Services contract, which commenced in March 2015.

#### Human Services Segment

The Human Services Segment provides national, state and county human services agencies with a variety of business process services and related consulting services for welfare-to-work, child support, higher education and K-12 special education programs.

*(amounts in thousands)*

|  | Three Months Ended March 31, 2015 | 2014 | Six Months Ended March 31, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $111,411 | $115,417 | $227,155 | $223,425 |
| Gross profit | 32,458 | 35,804 | 66,310 | 65,214 |
| Operating income | 13,935 | 17,276 | 30,088 | 29,612 |
| Gross profit percentage | 29.1% | 31.0% | 29.2% | 29.2% |
| Operating margin percentage | 12.5% | 15.0% | 13.2% | 13.3% |

Revenue and profit have declined for the three months ended March 31, 2015, compared to the corresponding period in the prior year, and increased for the six months ended March 31, 2015 compared to the respective period. The current fiscal year has seen significant effects from currency fluctuations. Revenues for the three and six month periods ended March 31, 2015 would have been $8.2 million and $13.1 million higher if the foreign exchange rates in fiscal year 2014 had prevailed through the current year.

Profit margins in fiscal year 2014 were higher due to a number of short-term consulting projects, which typically enjoy higher margins. The margin for the six month period ended March 31, 2015 also had the benefit of incremental revenue and profit from change orders in the first quarter of fiscal year 2015.

In March 2015, we were informed that we have been successful in expanding our existing welfare-to-work contract in Australia, starting in July 2015. Although this contract is anticipated to be profitable, the costs of expanding our operations and the structure of reimbursement under the new arrangement is expected to reduce our fourth quarter earnings by between $6 million and $9 million.

### Liquidity and Capital Resources

Our principal source of liquidity has been our cash flows from operations which, through March 31, 2015, have provided sufficient funds to fund working capital, capital expenditures, business combinations, share repurchases and dividends. In April 2015, we acquired Acentia and utilized $225 million of funds from a revolving credit facility to cover the majority of the $294 million estimated purchase price.

Our operating cash inflows are typically driven by our contracts and influenced by payment terms in contracts. For many contracts, including two new projects in the United Kingdom, we are frequently reimbursed up front for the costs of our start-up operations. Although there may be a gap between incurring costs and receiving this reimbursement, we have sufficient funds to cover these costs. Other factors that may cause delays in our realization of customer receipts include customer payments based upon delivering outcomes, which may not correspond with the costs incurred to achieve these outcomes, and short-term payment delays where government budgets are constrained. Our receivables have increased in the first half of fiscal year 2015, driven in part by significant outstanding invoices in the United Kingdom to recover start-up costs related to two large contracts. The related contracts commenced operations in March and, accordingly, revenue included in the calculation of days sales outstanding (DSO) included only one month of revenue whereas receivables included significant billings for start-up costs. The effect on DSO was approximately five days. We do not anticipate any issues in collecting these balances.

Days sales outstanding, or DSO, is a measure of how efficiently we manage the billing and collection of our receivable balances. We calculate DSO by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days. DSO was 70 as of March 31, 2015, compared to 58 as of December 31, 2014.

Our credit facility allows us to borrow up to $400 million, subject to standard covenants. We anticipate that our cash flows from operations over the course of the next two years should be sufficient to meet our day-to-day requirements, as well as pay our interest and repay the principal on our existing borrowings.

At March 31, 2015, our foreign subsidiaries held approximately $37 million in cash and cash equivalents. We have no requirement or intent to remit this cash to the United States. We consider undistributed earnings of our foreign subsidiaries to be indefinitely reinvested outside of the United States and, accordingly, no U.S. deferred taxes have been recorded with respect to such earnings in accordance with the relevant accounting guidance for income taxes. Should the earnings be remitted as dividends, we may be subject to additional U.S. taxes, net of allowable foreign tax credits. It is not practicable to estimate the amount of any additional taxes which may be payable on the undistributed earnings given the various tax planning alternatives we could employ should we decide to repatriate these earnings in a tax-efficient manner.

#### Cash Flows

*(amounts in thousands)*

| Net cash provided by (used in): | Six Months Ended March 31, 2015 | 2014 |
| --- | ---: | ---: |
| Operating activities | $62,066 | $76,460 |
| Investing activities | (47,191) | (19,349) |
| Financing activities | (52,515) | (50,378) |
| Effect of exchange rate changes on cash and cash equivalents | (5,937) | (1,027) |
| Net increase/(decrease) in cash and cash equivalents | $(43,577) | $5,706 |

Cash provided by operating activities declined 19% to $62.1 million for the six months ended March 31, 2015, compared with the period in the prior fiscal year, notwithstanding an increase in revenue and profitability. This decline was driven by increases in our working capital, particularly in accounts receivable, caused by growth in our business and the timing of certain receivable payments.

Cash used in investing activities was $47.2 million for the six months ended March 31, 2015, compared to $19.3 million for the six months ended March 31, 2014. This increase has been driven by significant investment in our infrastructure in the United States and the United Kingdom. These types of capital investments typically occur in five-to-seven year cycles. The investments include: facilities, fixed assets, and upgrades in our telephony and back office data centers. We believe these prudent investments will help drive efficiencies in future periods.

Cash used in financing activities was $52.5 million and $50.4 million for the six months ended March 31, 2015 and 2014, respectively. We utilized $32.6 million and $34.7 million, respectively, in repurchasing common stock.

The effects of exchange rates reduced our cash balances by $5.9 million in the six months ended March 31, 2015, principally in balances denominated in the Australian Dollar and British Pound.

To supplement our statements of cash flows presented on a GAAP basis, we use the non-GAAP measure of free cash flows to analyze the funds generated from operations. We believe free cash flow is a useful basis for comparing our performance with our competitors. The presentation of non-GAAP free cash flows is not meant to be considered in isolation, nor as an alternative to net income as an indicator of performance, nor as an alternative to cash flows from operating activities as a measure of liquidity. In addition, this non-GAAP financial measure, as determined and presented by us, may not be comparable to other related or similarly titled measures used by other companies. We calculate free cash flow as follows:

*(amounts in thousands)*

|  | Six Months Ended March 31, 2015 | 2014 |
| --- | ---: | ---: |
| Cash provided by operating activities | $62,066 | $76,460 |
| Purchases of property and equipment | (44,226) | (9,516) |
| Capitalized software costs | (3,247) | (7,317) |
| Free cash flow | $14,593 | $59,627 |

### Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expenses. On an ongoing basis, we evaluate our estimates including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill and other long-lived assets, and amounts related to contingencies and income tax liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

We believe that we do not have material off-balance-sheet risk or exposure to liabilities that are not recorded or disclosed in our financial statements. While we have significant operating lease commitments for office space, those commitments are generally tied to the period of performance under related contracts. Additionally, although on certain contracts we are bound by performance bond commitments and standby letters of credit, we have not had any defaults resulting in draws on performance bonds. Also, we do not speculate in derivative transactions.

During the six months ended March 31, 2015, there were no significant changes to the critical accounting policies we disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended September 30, 2014.

## Market risk

As filed, 557 characters.

There have been no material changes in the information presented in Item 7A of our Annual Report on Form 10-K for the year ended September 30, 2014.

On April 1, 2015, we borrowed $225 million from our credit facility to assist in acquiring Acentia. Our interest rates are based upon our leverage, as defined in our loan agreement, and market interest rates. Accordingly, changes in interest rates will affect our results prospectively. To mitigate this risk, we entered into a derivative transaction to fix the interest rate on $80 million of this balance.

## Controls and procedures

As filed, 1,813 characters.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Following the end of the fiscal quarter, we acquired both Acentia and Remploy. We have reviewed and identified the existing key controls in these entities and will integrate these entities into our existing control environment over the course of the next few months.

## Risk factors

As filed, 434 characters.

In connection with information set forth in this Form 10-Q, the factors discussed under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2014 should be considered. The risks included in the Form 10-K could materially and adversely affect our business, financial condition and results of operations. There have been no material changes to the factors discussed in our Form 10-K for the year ended September 30, 2014.

Filed May 8, 2015.
Source: SEC EDGAR, the filing index for accession 0001104659-15-035883. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
